B cell reconstitution and t helper cell balance after rituximab treatment of active primary sjögren's syndrome

Arthritis and Rheumatism

Volumn 63, Issue 4, 2011, Pages 1116-1123

  Abdulahad, W H ^a   Meijer, J M ^a   Kroese, F G M ^a   Meiners, P M ^a   Vissink, A ^a   Spijkervet, F K L ^a   Kallenberg, C G M ^a   Bootsma, H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; PLACEBO; RITUXIMAB;

ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EFFECTOR CELL; FLOW CYTOMETRY; HELPER CELL; HUMAN; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; SJOEGREN SYNDROME;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD27; ANTIRHEUMATIC AGENTS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL COUNT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; SJOGREN'S SYNDROME; T-LYMPHOCYTES, HELPER-INDUCER; TIME FACTORS;

EID: 79953712616     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30236     Document Type: Article

References (15)

1. Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L, Wolff A. Sjögren's syndrome: the diagnostic potential of early oral manifestations preceding hyposalivation/xerostomia. J Oral Pathol Med 2005;34:1-6 (Pubitemid 40142922)
2. Hansen A, Lipsky PE, Dorner T. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue. Arthritis Res Ther 2007;9:218
3. Meijer JM, Meiners PM, Vissink A, Spijkervet FK, Abdulahad W, Kamminga N, et al. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebocontrolled trial. Arthritis Rheum 2010;62:960-8
4. Liossis SN, Sfikakis PP. Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells. Clin Immunol 2008;127:280-5
5. Duddy ME, Alter A, Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation? J Immunol 2004;172:3422-7 (Pubitemid 38337921)
6. Vitetta ES, Fernandez-Botran R, Myers CD, Sanders VM. Cellular interactions in the humoral immune response. Adv Immunol 1989;45:1-105 (Pubitemid 19195506)
7. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006;203:1693-700 (Pubitemid 44036275)
8. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005;105:4390-8
9. Pers JO, Devauchelle V, Daridon C, Bendaoud B, Le Berre R, Bordron A, et al. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome. Arthritis Rheum 2007;56:1464-77 (Pubitemid 46764075)
10. Vallerskog T, Gunnarsson I, Widhe M, Risselada A, Klareskog L, van Vollenhoven R, et al. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol 2007;122:62-74 (Pubitemid 46026695)
11. Vigna-Perez M, Abud-Mendoza C, Hernandez-Castro B, Paredes- Saharopulos O, Gonzalez-Amaro R. In vivo effect of rituximab on regulatory T cells and apoptosis in patients with systemic lupus erythematosus. J Rheumatol 2006;33:420-1
12. Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, et al. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. J Autoimmun 2005;24:235-42 (Pubitemid 40545886)
13. Li X, Li X, Qian L, Wang G, Zhang H, Wang X, et al. T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome. J Rheumatol 2007;34: 2438-45 (Pubitemid 350230668)
14. Liu MF, Lin LH, Weng CT, Weng MY. Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjögren's syndrome. Lupus 2008;17:34-9
15. Christodoulou MI, Kapsogeorgou EK, Moutsopoulos ̀NM, Moutsopoulos HM. Foxp3+ T-regulatory cells in Sjögren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am J Pathol 2008;173:1389-96